ANNOUNCEMENT

MedCity CONVERGE gathers payers, providers, medtech, pharma, digital health, investors, policymakers and more.

Yu: Government’s role is to influence magnitude, timing and velocity of innovation

July 10, 2012 1:31 pm by | 0 Comments

Chris Seper and Will Yu

The common refrain in mid-June was that the U.S. Supreme Court decision didn’t matter because the innovation train had left the station. It’s easy to say that — particularly now that the high court upheld most of the Affordable Care Act.

But where would we be if Obamacare hadn’t kicked important changes in the industry into gear back in 2010? Would we still be debating the merits of accountable care organizations? Would any unemployed 25-year-olds be on their parents’ insurance? Would we have any data on impact of the medical loss ratio?

Wil Yu says that making these things happen more quickly is what the federal government is supposed to do. He opened the day at CONVERGE in Philadelphia today with a history lesson about one of the first clinical trials.

 

 

You could blame the lack of email for the fact that it took the British Navy 200 years to add lemons to the menu on all their ships. But then Yu shared a quote about the need for improving healthcare IT.

“The need for health IT stems in large part from increasingly rapid change in the pattern of illness in the U.S. and from equally significant changes in the way medicine is practiced. The emphasis here is on the importance of developing as rapidly as possible to improve quality and decrease the cost of medical care.”

He asked the audience what decade this recommendation came from. Most of the crowd guessed the ’80s; no one realized that this advice was given to President John F. Kennedy in 1963. Maybe email doesn’t make any difference.

Yu is the director of innovations in the Office of the National Coordinator for Health IT in Health and Human Services. He said that the government was focused on creating a new infrastructure to support innovators and adopters.

“Many existing stakeholders are not culturally, organizational and strategically equipped to adopt or acquire new innovations methodically,” he said. “For innovators, we are supporting the market environment with aligned programs and policies. One example is data infrastructure standards.”

For adopters, Yu said the government is using priorities, policies and programs to encourage existing stakeholders to adopt and scale new technologies and services.

Yu’s department has sponsored many challenges as part of this work including one to bring attention to domestic violence. He directed the audience to challenge.gov to see other current and past examples.

“It literally took an act of Congress to allow all departments in the government to sponsor challenges,” he said.

There are 15 live health-centric challenges with prizes ranging from $425 for a photo contest to $500,000 for a Medicaid challenge.

Yu’s last comment was that getting the word out to entrepreneurs was one of the biggest challenges his office faced. Maybe email, combined with Facebook, Twitter, blogs and good, old-fashioned word of mouth will ensure faster dissemination of this information than the results of the vitamin C/scurvy clinical trial.

Copyright 2013 MedCity News. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Know What's Next in Medical Innovation

Get the latest stories, carefully selected by our editorial team, in your inbox each morning.



Veronica Combs

By Veronica Combs

I am the editor in chief at MedCityNews.com. I started writing and editing in the print world and joined a dotcom right before the 2000 crash. I was at TechRepublic/CNET/BNET for 7 years. Health was more interesting to me than the latest version of Windows, so I left for a startup tracking prescription drug news. A year later, MedTrackAlert was acquired by HealthCentral, so I shifted to audience research. The fun of daily news and interviewing smart people brought me to MedCity News in February 2012.
More posts by Author

0 comments

Stay Up To Date

Next Story
How Chinese country of origin rules ultimately hurt U.S. medical device manufacturing jobs
Close